News Snapshot:
TIANJIN, Jan. 11 (Xinhua) -- Researchers in north China's Tianjin Municipality have developed a new synthetic enzyme with great application potential in treating neuroinflammation including Alzheimer's disease (AD) and cerebral injury. The enzyme, named "clusterzyme," was designed by the researchers from Tianjin University through single-atom substitutions. It has been proven catalytically potent and selective for modulation of neuroinflammation. Its antioxidant activity is 160 times that of water-soluble natural Vitamin E and nine times that of anthocyanin, according to the team. In the experiments, the clusterzyme effectively eased neuroinflammation in mice with brain injuries and significantly decreased their inflammation factors. In...
